Related Experiment Videos

Structure and properties of dermatan sulphate proteoglycans

¹Department of Medical and Physiological Chemistry, Lund University, Sweden.

Biochemical Society Transactions

|November 1, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.

Lancet (London, England)·2009

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.

Annals of the rheumatic diseases·2008

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.

Annals of the rheumatic diseases·2005

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists.

Annals of the rheumatic diseases·2005

Altered dermatan sulfate proteoglycan synthesis in fibroblast cultures established from skin of patients with systemic sclerosis.

The Journal of rheumatology·1996

Biosynthesis of dermatan sulphate proteoglycans. The effect of beta-D-xyloside addition on the polymer-modification process in fibroblast cultures.

The Biochemical journal·1991

See all related articles